tirzepatide weight regain after stopping the withdrawal of (Zepbound) may wipe out many of the cardiometabolic gains made during weight loss, a post-hoc analysis of the SURMOUNT-4 trial indicated. Read more at: https://www.medpagetoday.com/endocrinology/obesity Rebound weight gain after stopping
Description
Leung M., MEYhFER S
doi: 10.1089/dia.2019.0185

Some skeletal muscles lost around 6 percent of their size, while others remained unchanged
Exposures: Current use of DPP-4 inhibitors and GLP-1 analogues (alone or in combination therapy) compared with current use of at least 2 oral antidiabetic drugs

The immunomodulatory effects of GLP-1 receptor agonists in neurogenerative diseases and ischemic stroke treatment

Safety is paramount, especially regarding compounded medications